Fund shareholders of Biogen Inc
ISIN US09062X1037 · United States · LEI W8J5WZB5IY3K0NDQT671
- Fund shareholders
- 831
- Of which ETFs
- 244 587 other funds
- Value held
- 12.4B $ 1.3B SEK · 50.6M €
- Share of capital
- 45.9 % of 147.8M shares on Jul 27, 2026
831 funds hold this company. This table lists the 827 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS | 8,359,880 | 1.5B $ | 2.12 % | 5.66 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,654,936 | 853.4M $ | 0.04 % | 3.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 3,730,577 | 683.9M $ | 0.05 % | 2.52 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 3,269,520 | 599.4M $ | 0.38 % | 2.21 % | as of Mar 31, 2026 ↗ |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 3,169,409 | 581M $ | 0.29 % | 2.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2,526,097 | 478.1M $ | 1.30 % | 1.71 % | as of Apr 30, 2026 ↗ |
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 2,332,567 | 427.6M $ | 1.74 % | 1.58 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P 500 ETF iShares Trust | 1,888,033 | 346.1M $ | 0.05 % | 1.28 % | as of Mar 31, 2026 ↗ |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 1,866,971 | 358.1M $ | 0.05 % | 1.26 % | as of Feb 28, 2026 ↗ |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 1,357,618 | 248.9M $ | 0.11 % | 0.92 % | as of Mar 31, 2026 ↗ |
| VANGUARD PRIMECAP CORE FUND VANGUARD FENWAY FUNDS | 1,316,936 | 241.4M $ | 1.78 % | 0.89 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 1,242,366 | 238.3M $ | 0.11 % | 0.84 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,091,046 | 200M $ | 2.46 % | 0.74 % | as of Mar 31, 2026 ↗ |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 1,067,952 | 195.8M $ | 0.51 % | 0.72 % | as of Mar 31, 2026 ↗ |
| VANGUARD MID-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 954,017 | 174.9M $ | 0.50 % | 0.65 % | as of Mar 31, 2026 ↗ |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 885,775 | 167.7M $ | 0.19 % | 0.60 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 827,362 | 151.7M $ | 0.05 % | 0.56 % | as of Mar 31, 2026 ↗ |
| Disciplined Value Mid Cap Fund John Hancock Funds III | 781,583 | 143.3M $ | 0.65 % | 0.53 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Value Discovery Fund Fidelity Devonshire Trust | 772,400 | 146.2M $ | 0.92 % | 0.52 % | as of Apr 30, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 719,692 | 131.9M $ | 0.39 % | 0.49 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 712,650 | 134.9M $ | 1.99 % | 0.48 % | as of Apr 30, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 644,300 | 123.6M $ | 0.38 % | 0.44 % | as of Feb 28, 2026 ↗ |
| Pacer US Cash Cows 100 ETF Pacer Funds Trust | 642,650 | 121.6M $ | 0.67 % | 0.43 % | as of Apr 30, 2026 ↗ |
| PRIMECAP Odyssey Growth Fund PRIMECAP Odyssey Funds | 615,350 | 116.5M $ | 2.14 % | 0.42 % | as of Apr 30, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 558,815 | 102.4M $ | 0.21 % | 0.38 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 541,113 | 102.4M $ | 0.20 % | 0.37 % | as of Apr 30, 2026 ↗ |
| PRIMECAP Odyssey Stock Fund PRIMECAP Odyssey Funds | 533,140 | 100.9M $ | 2.27 % | 0.36 % | as of Apr 30, 2026 ↗ |
| Fidelity Low-Priced Stock Fund Fidelity Puritan Trust | 508,542 | 96.3M $ | 0.40 % | 0.34 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 497,200 | 91.2M $ | 0.40 % | 0.34 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 444,855 | 81.6M $ | 1.10 % | 0.30 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 440,425 | 84.5M $ | 0.42 % | 0.30 % | as of Feb 28, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 429,853 | 78.8M $ | 3.47 % | 0.29 % | as of Mar 31, 2026 ↗ |
| MFS Mid Cap Value Fund MFS SERIES TRUST XI | 414,847 | 76.1M $ | 0.48 % | 0.28 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 364,188 | 69.9M $ | 1.07 % | 0.25 % | as of Feb 27, 2026 ↗ |
| iShares Russell 1000 Value ETF iShares Trust | 335,747 | 61.6M $ | 0.09 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Schwab S&P 500 Index Fund SCHWAB CAPITAL TRUST | 326,585 | 61.8M $ | 0.04 % | 0.22 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPDR SERIES TRUST | 308,328 | 56.5M $ | 0.05 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 299,435 | 57.4M $ | 1.07 % | 0.20 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 294,100 | 55.7M $ | 2.92 % | 0.20 % | as of Apr 30, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 277,452 | 484.6M SEK | 0.04 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 274,195 | 52.6M $ | 0.04 % | 0.19 % | as of Feb 28, 2026 ↗ |
| CAPITAL GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 263,550 | 48.3M $ | 2.10 % | 0.18 % | as of Mar 31, 2026 ↗ |
| iShares S&P 500 Value ETF iShares Trust | 253,224 | 46.4M $ | 0.10 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Patient Opportunity Trust Advisor Managed Portfolios | 250,000 | 45.8M $ | 2.64 % | 0.17 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Equity Income Fund T. ROWE PRICE EQUITY INCOME FUND, INC. | 237,000 | 43.4M $ | 0.27 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI U.S. Low Volatility Index Fund Fidelity Salem Street Trust | 231,638 | 43.8M $ | 0.21 % | 0.16 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 216,917 | 41.6M $ | 0.04 % | 0.15 % | as of Feb 28, 2026 ↗ |
| iShares Russell Mid-Cap Value ETF iShares Trust | 210,347 | 38.6M $ | 0.27 % | 0.14 % | as of Mar 31, 2026 ↗ |
| ALGER FOCUS EQUITY FUND ALGER INSTITUTIONAL FUNDS | 205,149 | 38.8M $ | 0.64 % | 0.14 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 195,918 | 37.6M $ | 0.26 % | 0.13 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 185,286 | 34M $ | 0.04 % | 0.13 % | as of Mar 31, 2026 ↗ |
| JPMorgan Large Cap Value Fund JPMorgan Trust II | 182,195 | 33.4M $ | 0.68 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Large Company ETF SCHWAB STRATEGIC TRUST | 179,440 | 34.4M $ | 0.14 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Fidelity Fund Fidelity Hastings Street Trust | 178,000 | 32.6M $ | 0.39 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Value Discovery Fund Fidelity Puritan Trust | 176,300 | 33.4M $ | 0.88 % | 0.12 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 500(R) Value ETF SPDR SERIES TRUST | 172,483 | 31.6M $ | 0.10 % | 0.12 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Value Factor ETF iShares Trust | 172,461 | 32.6M $ | 0.27 % | 0.12 % | as of Apr 30, 2026 ↗ |
| VANGUARD LARGE-CAP INDEX FUND VANGUARD INDEX FUNDS | 172,280 | 31.6M $ | 0.05 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Large Cap Value Fund Bridge Builder Trust | 152,089 | 27.9M $ | 0.11 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 150,604 | 28.9M $ | 0.05 % | 0.10 % | as of Feb 28, 2026 ↗ |
| THE U.S. LARGE CAP VALUE SERIES DFA INVESTMENT TRUST CO | 139,082 | 26.3M $ | 0.09 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Diversified Stock Fund Fidelity Destiny Portfolios | 139,000 | 25.5M $ | 0.70 % | 0.09 % | as of Mar 31, 2026 ↗ |
| S&P 500 Index Master Portfolio Master Investment Portfolio | 134,491 | 24.7M $ | 0.05 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI U.S. Value Index Fund Fidelity Salem Street Trust | 126,829 | 24M $ | 0.30 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 125,832 | 23.8M $ | 0.04 % | 0.09 % | as of Apr 30, 2026 ↗ |
| iShares Core S&P U.S. Value ETF iShares Trust | 123,967 | 22.7M $ | 0.09 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 121,828 | 23.1M $ | 0.03 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 120,535 | 23.1M $ | 0.03 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Victory Pioneer Core Equity Fund Victory Portfolios IV | 117,623 | 21.6M $ | 1.12 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 114,920 | 21.8M $ | 0.05 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Fidelity Mid-Cap Stock Fund Fidelity Concord Street Trust | 114,865 | 21.7M $ | 0.25 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 110,502 | 20.3M $ | 0.22 % | 0.07 % | as of Mar 31, 2026 ↗ |
| JPMorgan Active Value ETF J.P. Morgan Exchange-Traded Fund Trust | 109,383 | 20.1M $ | 0.34 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Intrinsic Opportunities Fund Fidelity Puritan Trust | 107,400 | 20.3M $ | 0.68 % | 0.07 % | as of Apr 30, 2026 ↗ |
| ALGER SPECTRA FUND ALGER FUNDS II | 105,355 | 19.9M $ | 0.46 % | 0.07 % | as of Apr 30, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 104,478 | 19.2M $ | 0.04 % | 0.07 % | as of Mar 31, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 103,216 | 19.5M $ | 2.23 % | 0.07 % | as of Apr 30, 2026 ↗ |
| iShares ESG Aware MSCI USA ETF iShares Trust | 101,028 | 19.4M $ | 0.12 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 96,300 | 168.2M SEK | 0.17 % | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 95,673 | 17.5M $ | 0.28 % | 0.06 % | as of Mar 31, 2026 ↗ |
| MFS Blended Research Mid Cap Equity Fund MFS Series Trust X | 94,516 | 18.1M $ | 0.71 % | 0.06 % | as of Feb 28, 2026 ↗ |
| ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 94,204 | 17.8M $ | 0.54 % | 0.06 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Equity Index 500 Fund T. ROWE PRICE INDEX TRUST, INC. | 91,847 | 16.8M $ | 0.05 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Low-Priced Stock K6 Fund Fidelity Puritan Trust | 91,429 | 17.3M $ | 0.40 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity New Millennium Fund Fidelity Mt. Vernon Street Trust | 91,100 | 17.5M $ | 0.32 % | 0.06 % | as of Feb 28, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 90,075 | 16.5M $ | 0.20 % | 0.06 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 87,500 | 16M $ | 0.40 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 87,259 | 16M $ | 0.06 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 86,538 | 16.6M $ | 0.07 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 86,493 | 15.9M $ | 0.04 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 86,146 | 16.3M $ | 0.04 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 85,199 | 16.3M $ | 0.04 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 1000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 84,841 | 16.3M $ | 0.09 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Swedbank Robur Aktiefond Pension Swedbank Robur Fonder AB | 83,100 | 145.1M SEK | 0.14 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 82,533 | 15.1M $ | 0.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Fundamental U.S. Large Company Index Fund SCHWAB CAPITAL TRUST | 79,042 | 15M $ | 0.12 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Large-Cap Value ETF SCHWAB STRATEGIC TRUST | 77,358 | 14.8M $ | 0.09 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD FTSE SOCIAL INDEX FUND VANGUARD WORLD FUND | 76,395 | 14.7M $ | 0.06 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 76,365 | 14.5M $ | 0.04 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 75,443 | 13.8M $ | 3.72 % | 0.05 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 5.05 % | as of Apr 30, 2026 ↗ |
| MERCH-UNIVERSAL, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 4.15 % | as of Dec 31, 2025 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 3.72 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 3.67 % | as of Apr 30, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 3.63 % | as of Apr 30, 2026 ↗ |
| First Trust Nasdaq Pharmaceuticals ETF First Trust Exchange-Traded Fund VI | 3.62 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.47 % | as of Mar 31, 2026 ↗ |
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 3.45 % | as of Dec 31, 2025 ↗ |
| The Free Markets ETF Tidal Trust I | 3.40 % | as of Feb 28, 2026 ↗ |
| Alger Mid Cap 40 ETF Alger ETF Trust | 3.32 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 766 | +47 | 67,078,108 | +6.5 % |
| 2026Q1 | 719 | -1 | 62,971,523 | +5.5 % |
| 2025Q4 | 720 | +20 | 59,708,137 | -2.5 % |
| 2025Q3 | 700 | -22 | 61,228,423 | -2.0 % |
| 2025Q2 | 722 | +8 | 62,471,837 | -1.2 % |
| 2025Q1 | 714 | -49 | 63,217,302 | -2.5 % |
| 2024Q4 | 763 | -14 | 64,810,261 | -3.6 % |
| 2024Q3 | 777 | -4 | 67,231,656 | +1.9 % |
| 2024Q2 | 781 | -46 | 65,957,473 | +7.9 % |
| 2024Q1 | 827 | -55 | 61,122,879 | +2.1 % |
| 2023Q4 | 882 | 59,883,539 |
Institutional managers
987 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 15,974,601 | 2.9B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 14,757,607 | 2.7B $ | as of Mar 31, 2026 |
| FMR LLC | 12,807,541 | 2.3B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 7,167,922 | 1.3B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,342,602 | 793.4M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,961,641 | 543M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,170,940 | 398M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,016,009 | 378.1M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,923,557 | 346.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,745,255 | 320M $ | as of Mar 31, 2026 |
| Boston Partners | 1,700,078 | 311.7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,446,579 | 265.2M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,377,568 | 252.5M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,349,832 | 247.5M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,160,989 | 212.8K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,156,369 | 212M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,149,394 | 210.7M $ | as of Mar 31, 2026 |
| VAN ECK ASSOCIATES CORP | 1,079,861 | 198K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,079,119 | 197.9M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 1,063,828 | 195M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,051,094 | 192.7M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 913,328 | 168.3M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 809,617 | 148.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 805,050 | 147.6M $ | as of Mar 31, 2026 |
| Amundi | 790,827 | 145M $ | as of Mar 31, 2026 |
Declared shareholders of Biogen Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 11.30 % | 16,652,975 | as of May 29, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 7.48 % | 10,989,562 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Biogen Inc
194 funds declare 386 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Biogen Inc". https://titelia.com/en/stocks/biogen-inc-US09062X1037